bel8-k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K


CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported):  
November 25, 2013
 
BEL FUSE INC.
(Exact Name of Registrant as Specified in its Charter)

New Jersey
 
0-11676
 
22-1463699
(State or Other Jurisdiction of Incorporation)
 
(Commission
File Number)
 
(IRS Employer Identification No.)


206 Van Vorst Street, Jersey City, New Jersey
 
07302
(Address of principal executive offices)
 
(Zip Code)

Registrant's telephone number, including area code:  (201) 432-0463


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[      ]   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

                  [      ]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
[      ]   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

                  [      ]   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 

 

 

 
ITEM 8.01. OTHER EVENTS.
 
 
On November 25, 2013, Bel Fuse Inc. (the “Company”) issued a press release announcing that its joint petition for certiorari with the United States Supreme Court in the SynQor, Inc. v. Artesyn Technologies, Inc., et al. lawsuit, originally brought in the United States District Court, Eastern District of Texas in November 2007, has been denied.  Accordingly, Bel has paid to SynQor, Inc. previously awarded damages plus interest, totaling $10.9 million.  Of this amount, $8.1 million was recorded by Bel as a litigation charge in its consolidated statement of operations for the fourth quarter of 2010; $1.9 million is covered through an indemnification agreement with one of Bel's customers; and $0.6 million was recorded as an expense by the Company during the second quarter of 2011. A copy of this press release is being filed as Exhibit 99.1 to this Current Report on Form 8-K.
 
 
 
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.
 
 
(d) Exhibits
 
As described in Item 8.01 of this Report, the following Exhibit is filed as part of this Current Report on Form 8-K:
 
99.1 Press Release of Bel Fuse Inc. dated November 25, 2013.
 
 

 
 
 

 
 
SIGNATURE
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Date: November 27, 2013
BEL FUSE INC.
 
(Registrant)
   
   
By:   
/s/ Daniel Bernstein
 
Daniel Bernstein
 
President and Chief Executive Officer
 

 
 

 
 
 
EXHIBIT INDEX
 
Exhibit No.  
Description
   
 
99.1   Press release of Bel Fuse Inc. dated November 25, 2013.

 
ex99-1.htm
Exhibit 99.1
 
 
bel logo
 
 
 
FOR IMMEDIATE RELEASE
Bel Fuse Inc.
206 Van Vorst Street
Jersey City,  NJ 07302
www.belfuse.com
tel 201.432.0463
fax 201.432.9542
 
 
 
 
Investor Contact:
Neil Berkman Associates
(310) 477-3118 
info@berkmanassociates.com
 
Company Contact:
Daniel Bernstein
President & CEO
(201) 432-0463
   
 

Bel Announces Resolution of SynQor Lawsuit


JERSEY CITY, New Jersey, November 25, 2013 -- Bel Fuse Inc. (NASDAQ:BELFA and NASDAQ:BELFB) announced today that its joint petition for certiorari with the United States Supreme Court in the SynQor, Inc. v. Artesyn Technologies, Inc., et al. lawsuit, originally brought in the United States District Court, Eastern District of Texas in November 2007, has been denied.  Accordingly, Bel has paid to SynQor, Inc. previously awarded damages plus interest, totaling $10.9 million.  Of this amount, $8.1 million was recorded by Bel as a litigation charge in its consolidated statement of operations for the fourth quarter of 2010; $1.9 million is covered through an indemnification agreement with one of Bel's customers; and $0.6 million was recorded as an expense by the Company during the second quarter of 2011.
The lawsuit alleged that eleven defendants, including Bel, infringed SynQor's patents covering certain power products. With respect to Bel, the plaintiff claimed that the Company infringed its patents related to unregulated bus converters and/or point-of-load (POL) converters used in intermediate bus architecture power supply systems.

About Bel
Bel (www.belfuse.com) and its divisions are primarily engaged in the design, manufacture, and sale of products used in networking, telecommunications, high-speed data transmission, commercial aerospace, military, transportation, and consumer electronics.  Products include magnetics (discrete components, power transformers and MagJack® connectors with integrated magnetics), modules (DC-DC converters and AC-DC power supplies, integrated analog front-end modules and custom designs), circuit protection (miniature, micro and surface mount fuses) and interconnect devices (micro, circular and filtered D-Sub connectors, fiber optic connectors, passive jacks, plugs and high-speed cable assemblies).

Forward-Looking Statements
Except for historical information contained in this press release, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties.  Actual results could differ materially from Bel's projections.  Among the factors that could cause actual results to differ materially from such statements are: the market concerns facing our customers; the continuing viability of sectors that rely on our products; the effects of business and economic conditions; difficulties associated with integrating recently acquired companies; capacity and supply constraints or difficulties; product development, commercialization or technological difficulties; the regulatory and trade environment; risks associated with foreign currencies; uncertainties associated with legal proceedings; the market's acceptance of the Company's new products and competitive responses to those new products; and the risk factors detailed from time to time in the Company's SEC reports.  In light of the risks and uncertainties, there can be no assurance that any forward-looking statement will in fact prove to be correct. We undertake no obligation to update or revise any forward looking statements.


           *  *  *  *  *